References
- Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 2006;7:719-27. https://doi.org/10.1016/S1470-2045(06)70804-X
- Pignon JP, Tribodet H, Scagliotti GV, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552-9. https://doi.org/10.1200/JCO.2007.13.9030
- Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trials: PORT Metaanalysis Trialists Group. Lancet 1998;352:257-63. https://doi.org/10.1016/S0140-6736(98)06341-7
- Billiet C, Decaluwe H, Peeters S, et al. Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis. Radiother Oncol 2014;110:3-8. https://doi.org/10.1016/j.radonc.2013.08.011
- Lally BE, Zelterman D, Colasanto JM, Haffty BG, Detterbeck FC, Wilson LD. Postoperative radiotherapy for stage II or III nonsmall-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol 2006;24:2998-3006. https://doi.org/10.1200/JCO.2005.04.6110
- Douillard JY, Rosell R, De Lena M, et al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys 2008;72:695-701. https://doi.org/10.1016/j.ijrobp.2008.01.044
- Corso CD, Rutter CE, Wilson LD, Kim AW, Decker RH, Husain ZA. Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database. J Thorac Oncol 2015;10:148-55. https://doi.org/10.1097/JTO.0000000000000406
- Mikell JL, Gillespie TW, Hall WA, et al. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base. J Thorac Oncol 2015;10:462-71. https://doi.org/10.1097/JTO.0000000000000411
- Robinson CG, Patel AP, Bradley JD, et al. Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base. J Clin Oncol 2015;33:870-6. https://doi.org/10.1200/JCO.2014.58.5380
- Lee HW, Noh OK, Oh YT, et al. Radiation therapy-first strategy after surgery with or without adjuvant chemotherapy in stage IIIA-N2 non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2016;94:621-7. https://doi.org/10.1016/j.ijrobp.2015.11.020
- Jeong SH, Lee HW, Han JH, et al. Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology. Jpn J Clin Oncol 2008;38:661-9. https://doi.org/10.1093/jjco/hyn089
- Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004;57:1288-94. https://doi.org/10.1016/j.jclinepi.2004.03.012
- R Development Core Team. R: a language and environment for the statistical computing [Internet]. Vienna, Austria: The R Foundation; c2016 [cited 2016 Aug 18]. Available from: https://www.r-project.org/.
- Kim H, Lussier YA, Noh OK, Li H, Oh YT, Heo J. Prognostic implication of pulmonary function at the beginning of postoperative radiotherapy in non-small cell lung cancer. Radiother Oncol 2014;113:374-8. https://doi.org/10.1016/j.radonc.2014.11.007
- Keller SM, Adak S, Wagner H, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 2000;343:1217-22. https://doi.org/10.1056/NEJM200010263431703
- Bradley JD, Paulus R, Graham MV, et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group: RTOG 9705. J Clin Oncol 2005;23:3480-7. https://doi.org/10.1200/JCO.2005.12.120
- Wakelee HA, Stephenson P, Keller SM, et al. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590. Lung Cancer 2005;48:389-97. https://doi.org/10.1016/j.lungcan.2004.11.007
- Feigenberg SJ, Hanlon AL, Langer C, et al. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA nonsmall cell lung cancer. J Thorac Oncol 2007;2:287-92. https://doi.org/10.1097/01.JTO.0000263710.54073.b3
- Lee HC, Kim YS, Oh SJ, et al. The single institutional outcome of postoperative radiotherapy and concurrent chemoradiotherapy in resected non-small cell lung cancer. Radiat Oncol J 2014;32:147-55. https://doi.org/10.3857/roj.2014.32.3.147
- Shen WY, Ji J, Zuo YS, et al. Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial. Radiother Oncol 2014;110:120-5. https://doi.org/10.1016/j.radonc.2013.10.008
Cited by
- Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base vol.25, pp.5, 2016, https://doi.org/10.1245/s10434-018-6399-4
- Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base vol.25, pp.6, 2016, https://doi.org/10.1245/s10434-018-6441-6
- Diffusion-weighted imaging in evaluating the efficacy of concurrent chemoradiotherapy in the treatment of non-small cell lung cancer vol.104, pp.3, 2016, https://doi.org/10.5301/tj.5000612
- Study on the Dose Uncertainties in the Lung during Passive Proton Irradiation with a Proton Beam Range Compensator vol.72, pp.11, 2016, https://doi.org/10.3938/jkps.72.1369